The document discusses the development of the pharmaceutical cluster and healthcare system in Yaroslavl Region, Russia. It outlines investments in pharmaceutical plants by Nycomed and R-Pharm, the creation of an education and research center, and multilevel training programs involving universities. International conferences on clusters and public health have been held in the region. The goal is to strengthen the pharmaceutical industry and quality of healthcare through education, research, manufacturing investments and international cooperation.
1 of 18
More Related Content
Yaroslavl pharm cluster 2011 05-11
1. Yaroslavl Region
Government
Yaroslavl pharma cluster –
strengthening the position …
1
3. Yaroslavl Region
Government Global Policy Forum 2009,2010,2011
Participants :
?the President of the Russian Federation
Mr. Dmitry A. Medvedev
? the Prime Minister of Spain
Mr. José Luis Rodriguez Zapatero
? the Prime Minister of the French Republic
Mr. Fran?ois Fillon
? the President of the Republic of Korea
Mr. Lee Myung-bak
?the Prime Minister of Italy Mr. Silvio Berlusconi
? the special envoy of the Prime Minister of Japan
Mr. Yukio Hatoyama
?as well as prominent government and public figures, business representatives, scientists and
experts, journalists from almost forty countries
3
5. Yaroslavl Region
Government
Cluster Development
16
15
14
13
12
11
10
9 Educational projects
8 Research projects
7
6 Manufacturing
5
4
3
2
1
0
2009 2010 2011
5
6. Yaroslavl Region
Government Pharmaceutical Plants
Nycomed in Yaroslavl
? First foreign “pharma” investor in Yaroslavl (joint press-conf. in Sept. 2009)
? Investing EUR 75 mln. into modern GMP factory
? Support from the Russian PM Putin (Groundbreaking Ceremony in June 2010)
? Project develops ahead of schedule (Construction of the outer part finished in March 2011)
6
7. Yaroslavl Region
Government Pharmaceutical Plants
R-Pharm in Yaroslavl
Fully complies or exceeds the requirements of FDA/EMEA:
21 CFR Part 210 - Current Good Manufacturing Practice In Manufacturing, Processing,
Packing, or Holding of Drugs, General
21 CFR Part 211 - Current Good Manufacturing Practice For Finished Pharmaceuticals
GAMP 5 - Quality control systems based on Good Automation Manufacturing Practice 5
guidelines implemented.
R-Pharm project complies with the quality standards ASTM E2500
7
8. Yaroslavl Region Pharmaceutical education
Government
and R&D center
A Technology Transfer Center is being created to combine the activities of the leading
Yaroslavl education institutions with investors for development of innovative and import-
replacing medications and for training professional personnel for the modern
pharmaceutical industry.
It is 8600 sq.m. big, and is made possible with the Federal Support of over 32 MIO US
Dollars grant.
This center will become the core of the scientific research infrastructure for the
pharmaceutical industry.
It will coordinate development of new Russian highly-efficient, innovative and import-
replacing medications.
8
9. Yaroslavl Region Multilevel System of Professional Education
Government
Center for Pharmaceutical
Education in Yaroslavl
? Center for secondary education of the
pharma-related occupations with GMP
focus
? Pilot group started in Sept. 2010
? Staff for the whole cluster and potentially
beyond
? In partnership with Nycomed
? In line with the “Pharma-2020”
+ =
9
10. Yaroslavl Region Multilevel System of Professional Education
Government
Scholarship program
YSU YSTU
YSMA YSPU
- 150 students will get scholarships in 2011
- long-term training in the USA starts in summer 2011
- new training laboratory opens in YSMA in 2011
10
11. Yaroslavl Region
Government
Multilevel system of professionals training
Training programs for students
2011, March
The Yaroslavl State Technical University
FIOLAX? Academy
The Yaroslavl State Medical Academy
Employees from production departments, quality assurance and sales can now
expand their knowledge on the use and benefits of glass for pharma packaging
solutions.
11
12. Yaroslavl Region
Government
Multilevel system of professionals training
Second Russian Student Pharmaceutical Competition
27-29th January, 2011
32 teams from universities in 27 Russian cities
Project partners :
12
13. Yaroslavl Region Multilevel system of professionals training
Government
EDUCATION AND ACADEMIC MOBILITY CENTER fostered by Yaroslavl Medical Academy,
Olympus Company and Kanazawa Medical university to educate young therapists, surgeons
and endoscopists.
ЯГМА
13
14. The principle of development of the
Yaroslavl Region
Government regional health system
Development
Q
u
a
Standards
l
i
Realization of the necessity to improve t
the quality of medical services y
Time
14
15. Cooperation in the Field of Public Health and
Yaroslavl Region
Government Научно-образовательные проекты
Medical Science
Program on Optimization of Cardiological Medical Service in Yaroslavl Region
Supported by
-Novartis Pharma
-Russian Cardiology Scientific-Production Complex
-Russian Medical Society of Arterial Hypertension
Program objective
Development and implementation of an integrated approach to
decrease cardiovascular morbidity and mortality rate in
Yaroslavl Region Program tasks
-Survey of Cardiological and Therapeutical Medical System in
Yaroslavl Region
-Adaptation of standards of treatment for arterial hypertension
(AH) in order to optimize patients care and decrease
complications risk in Yaroslavl Region
-Implementation of standards of treatment for AH in all patient
care institutions
- Social campaign "Save your life - control blood pressure”
15
16. Yaroslavl Region
Government Scientific and educational projects
The Yaroslavl State Medical Academy
Ranbaxy Laboratories Limited
- broadеning thе sсopе of mеdiсal еduсational programs for prоfеssiоnal mеdiсal and
pharmaсеutiсal сommunity
- coopеration in arеa оf сliniсal trials as wеll as thе partiоipation in thе сrеatеd Сliniсal trials
сеntеr
16
17. Yaroslavl Region
Government International and Interregional cooperation
- creation of the interregional
council (with the representatives
of the regional pharmaceutical
clusters) for development of joint
projects and legislative initiatives
in the area of pharmaceutical
industry
- organization of the Interregional
Forum on the topical issues of
the regional pharmaceutical
clusters
- development of cooperation
with the foreign cluster systems
17